QC
KRMD icon

Quantessence Capital’s KORU Medical Systems KRMD Stock Holding History

Quantessence Capital’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,469
Closed -$41.8K – 323
2025
Q1 		$41.8K Buy
+16,469
New +$61.2K 0.01% 328

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Quantessence Capital's KRMD Position: Q2 2025 in Review

Quantessence Capital sold out of KORU Medical Systems (KRMD) in Q2 2025, closing a stake of 16,469 shares — an estimated $41.8K sold.

Quantessence Capital first reported a position in KRMD in Q1 2025 and held it in 1 quarter. The position peaked at $41.8K in Q1 2025. 79 funds tracked by Wall St. Rank hold KRMD as of Q2 2025.

  • Quantessence Capital reported no remaining KORU Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Quantessence Capital sold 16,469 KORU Medical Systems shares in Q2 2025, an estimated $41.8K.
  • Quantessence Capital first reported a position in KORU Medical Systems in Q1 2025 and held it in 1 quarter.
  • Quantessence Capital's KORU Medical Systems position peaked at $41.8K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.